Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic significance of different biomarkers in non-small cell lung cancer.

Oncology reports - 1 Jan 2000

Lavezzi A M, Santambrogio L, Bellaviti N, Biondo B, Nosotti M, Radice F, Matturri L

Abstract excerpt

The purpose of our study was to examine the prognostic significance of different biomarkers [DNA content, proliferating cell nuclear antigen labeling index (PCNA-LI), p53 mutation and apoptosis], in 152 surgically resected non-small cell lung cancer (NSCLC). The ploidy was carried out by densitometry; PCNA-LI, p53 and apoptosis were determined with immunohistochemistry. The results were correlated to histology,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to Ploidies

Share to Proliferating Cell Nuclear Antigen

Share to Survival Rate

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 10373663
DOI: 10.3892/or.6.4.819

Genes

PCNA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic significance of different biomarkers in non-small cell lung cancer.PMID 10373663Read ↗

Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.Semantic proximity Read ↗

Analysis of cell cycle regulator proteins in non-small cell lung cancerSemantic proximity Read ↗

Prognostic value and clinicopathologic correlation of p53 gene mutations and nuclear DNA content in human lung cancer: a prospective study.Semantic proximity Read ↗

Programmed Cell Death Ligand 1 Expression in Cytological and Surgical Non-Small Cell Lung Cancer Specimens in Association with EGFR Mutation and Overall Survival: A Single-Institution Experience.Semantic proximity Read ↗

Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs).Semantic proximity Read ↗

Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.Semantic proximity Read ↗

Association between p53 mutation and clinicopathological features of non-small cell lung cancer.Semantic proximity Read ↗

TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma.Semantic proximity Read ↗

Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.Semantic proximity Read ↗

Prognostic value of immunohistochemical expression of p53, bax, Bcl‐2 and Bcl‐x<sub>L</sub> in resected non‐small‐cell lung cancersSemantic proximity Read ↗

Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.Semantic proximity Read ↗

Mutations of p53 and K-ras genes as prognostic factors for non-small cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.